Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
brawn biotech ltd. stock

BRAWN BIOTECH LTD. Share Price

20.5 -0.92 (-4.29%)
Nov 21 2024 03:26 PM Pharmaceuticals NSE: BRAWN

BRAWN BIOTECH LTD. Share Price Update

As of the latest trading session, BRAWN BIOTECH LTD. share price is currently at 20.5, which is down by -0.92 from its previous closing. Today, the stock has fluctuated between 20.50 and 21.75. Over the past year, BRAWN BIOTECH LTD. has achieved a return of 11.50 %. In the last month alone, the return has been 0.56 %. Read More...

BRAWN BIOTECH LTD. Performance

Day Range

Low20.50 High21.75
21.03

52 Week Range

Low 14.63 High 27.82
21.03

BRAWN BIOTECH LTD. Share Price

530207

BRAWN

img img img img
No Data Available

Open Price

21.75

Prev. Close

21.42

Volume (Shares)

1244.00

Total traded value

.26

Upper Circuit

22.49

Lower Circuit

20.35

Note: The current prices & values are delayed, Login to your account for live updates.

BRAWN BIOTECH LTD. Fundamentals


(Standalone)

Market Cap (Cr) 6.30
PE Ratio (TTM) -3.46
Book Value / Share 14.10
Beta 0.42
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.34

BRAWN BIOTECH LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 3.30
Operating Expense 3.64
Net Profit -0.34
Net Profit Margin (%) -10.30
Earnings Per Share (EPS) -0.96
EBITDA -0.31
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 4.06
Operating Expense 4.59
Net Profit -0.53
Net Profit Margin (%) -13.05
Earnings Per Share (EPS) -1.83
EBITDA -0.50
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 3.45
Operating Expense 3.87
Net Profit -0.34
Net Profit Margin (%) -9.85
Earnings Per Share (EPS) -1.12
EBITDA -0.31
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 2.84
Operating Expense 3.45
Net Profit -0.61
Net Profit Margin (%) -21.47
Earnings Per Share (EPS) -2.02
EBITDA -0.58
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 2.92
Operating Expense 3.34
Net Profit -0.42
Net Profit Margin (%) -14.38
Earnings Per Share (EPS) -1.43
EBITDA -0.39
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 16.49
Operating Expense 18.12
Net Profit -1.54
Net Profit Margin (%) -9.33
Earnings Per Share (EPS) -5.14
EBITDA -1.44
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 22.23
Operating Expense 22.65
Net Profit -0.87
Net Profit Margin (%) -3.91
Earnings Per Share (EPS) -3.04
EBITDA -0.29
Effective Tax Rate (%) -112.19
Particulars MAR 2022 (Values in Cr)
Revenue 8.62
Operating Expense 10.74
Net Profit -1.64
Net Profit Margin (%) -19.02
Earnings Per Share (EPS) -5.25
EBITDA -2.01
Effective Tax Rate (%) 22.16
Particulars MAR 2021 (Values in Cr)
Revenue 34.98
Operating Expense 35.65
Net Profit -0.55
Net Profit Margin (%) -1.57
Earnings Per Share (EPS) -1.55
EBITDA -0.29
Effective Tax Rate (%) -52.77
Particulars MAR 2020 (Values in Cr)
Revenue 49.62
Operating Expense 48.97
Net Profit 0.59
Net Profit Margin (%) 1.18
Earnings Per Share (EPS) 2.01
EBITDA 0.90
Effective Tax Rate (%) 28.04
Particulars MAR 2024 (Values in Cr)
Book Value / Share 16.88
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -8.37
Particulars MAR 2023 (Values in Cr)
Book Value / Share 21.03
ROE % -12.86
ROCE % -5.74
Total Debt to Total Equity 0.00
EBITDA Margin -1.30
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.07
ROE % -20.49
ROCE % -24.95
Total Debt to Total Equity 0.00
EBITDA Margin -23.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.31
ROE % -6.09
ROCE % -3.49
Total Debt to Total Equity 0.00
EBITDA Margin -0.83
Particulars MAR 2020 (Values in Cr)
Book Value / Share 30.87
ROE % 6.58
ROCE % 9.57
Total Debt to Total Equity 0.00
EBITDA Margin 1.81
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.39
Total Assets 14.58
Total Liabilities 14.58
Total Equity 5.06
Share Outstanding 3000300
Price to Book Ratio 1.18
Return on Assets (%) -8.54
Return on Capital (%) -24.62
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.43
Total Assets 14.53
Total Liabilities 14.53
Total Equity 6.30
Share Outstanding 3000300
Price to Book Ratio 0.79
Return on Assets (%) -5.97
Return on Capital (%) -13.76
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 13.78
Total Liabilities 13.78
Total Equity 7.22
Share Outstanding 3000300
Price to Book Ratio 0.72
Return on Assets (%) -11.92
Return on Capital (%) -22.77
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.39
Total Assets 13.87
Total Liabilities 13.87
Total Equity 8.79
Share Outstanding 3000300
Price to Book Ratio 0.75
Return on Assets (%) -3.96
Return on Capital (%) -6.26
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.39
Total Assets 20.28
Total Liabilities 20.28
Total Equity 9.26
Share Outstanding 3000300
Price to Book Ratio 0.60
Return on Assets (%) 2.91
Return on Capital (%) 6.38
Particulars MAR 2024 (Values in Cr)
Net Income -1.54
Cash from Operations -0.02
Cash from Investing -0.01
Cash from Financing 0.00
Net change in Cash -0.04
Free Cash Flow -0.01
Particulars MAR 2023 (Values in Cr)
Net Income -0.41
Cash from Operations 0.30
Cash from Investing -0.09
Cash from Financing 0.00
Net change in Cash 0.21
Free Cash Flow 0.40
Particulars MAR 2022 (Values in Cr)
Net Income -2.11
Cash from Operations 0.18
Cash from Investing -0.29
Cash from Financing -0.06
Net change in Cash -0.17
Free Cash Flow 0.48
Particulars MAR 2021 (Values in Cr)
Net Income -0.35
Cash from Operations 0.30
Cash from Investing 0.00
Cash from Financing -0.03
Net change in Cash 0.00
Free Cash Flow 0.30
Particulars MAR 2020 (Values in Cr)
Net Income 0.81
Cash from Operations 0.15
Cash from Investing -0.01
Cash from Financing -0.04
Net change in Cash -0.14
Free Cash Flow 0.17
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 32.10 3.04 428.00 37.54 / 77.70
BLISS GVS PHARMA LTD 120.75 15.11 1.25 1271.52 92.25 / 148.95
CIPLA LTD 1471.35 25.74 4.18 118825.56 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 331.20 115.00 3.35 974.75 145.00 / 354.60
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 48.57 9.49 428.00 37.54 / 77.70
AMRUTAJAN HEALTH LTD 720.90 43.85 6.99 2084.17 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6497.50 126.19 23.91 16243.75 4050.15 / 8139.85
BLISS GVS PHARMA LTD 120.75 15.72 1.24 1271.52 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 21.90
  • 26 Days 21.40
  • 10 Days 22.00
  • 50 Days 20.80
  • 12 Days 21.90
  • 100 Days 21.70
  • 20 Days 21.70
  • 200 Days 21.40
21.59
PIVOT
First Resistance 21.83
Second Resistance 22.25
Third Resistance 22.49
First Support 21.17
Second Support 20.93
Third Support 20.51
RSI 52.57
MACD 0.43
Commodity Channel Index (CCI) 10.05
ADX 16.89
Williams % R -65.47

Over 1 Month

down

0.56

Over 3 Months

down

15.84

Over 6 Months

down

-19.16

Over 1 Year

down

11.50

Over 3 Years

down

4.07

Over 5 Years

down

-2.45

BRAWN BIOTECH LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

BRAWN BIOTECH LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
46.01
Promoter Holdings
53.63
FII
0.0
DII
0.34
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Brij Raj Gupta Shareholding of Promoter and Promoter Group 500174.0 16.67
Shashi Bala Gupta Shareholding of Promoter and Promoter Group 248253.0 8.27
Nitin Gupta Shareholding of Promoter and Promoter Group 193447.0 6.45
Brij Bala Gupta Shareholding of Promoter and Promoter Group 189000.0 6.3
Adarsh Kumar Gupta Shareholding of Promoter and Promoter Group 187650.0 6.25
Atul Gupta Shareholding of Promoter and Promoter Group 70750.0 2.36
A B Pharma P Ltd Shareholding of Promoter and Promoter Group 68100.0 2.27
Kavita Gupta Shareholding of Promoter and Promoter Group 44900.0 1.5
Daksha Kotak Public Shareholding 37093.0 1.24
Bhawna Goyal Shareholding of Promoter and Promoter Group 29700.0 0.99
Love Gupta Shareholding of Promoter and Promoter Group 13550.0 0.45
Mamta Gupta Shareholding of Promoter and Promoter Group 13200.0 0.44
Kush Gupta Shareholding of Promoter and Promoter Group 13050.0 0.43
Mamta Goel Shareholding of Promoter and Promoter Group 10770.0 0.36
Nupur Vibhuti Shareholding of Promoter and Promoter Group 2500.0 0.08
Surabhi Vibhuti Shareholding of Promoter and Promoter Group 2500.0 0.08
Shanta Bazaz Shareholding of Promoter and Promoter Group 2000.0 0.07
Ashok Kumar Aggarwal Shareholding of Promoter and Promoter Group 2000.0 0.07
Asha Aggarwal Shareholding of Promoter and Promoter Group 2000.0 0.07
Bishan Dass Dogra Shareholding of Promoter and Promoter Group 2000.0 0.07
Humaira Farooq Shareholding of Promoter and Promoter Group 2000.0 0.07
Maneet Kaur Chhatwal Shareholding of Promoter and Promoter Group 2000.0 0.07
Mohan C Bazar Shareholding of Promoter and Promoter Group 2000.0 0.07
Mohinder Singh Shah Shareholding of Promoter and Promoter Group 2000.0 0.07
Pradip Prasad Shareholding of Promoter and Promoter Group 2000.0 0.07
Tilak Raj Nijhara Shareholding of Promoter and Promoter Group 2200.0 0.07
Basant Kumar Goswami Shareholding of Promoter and Promoter Group 1600.0 0.05

BRAWN BIOTECH LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2018-09-12 1.0 Final 2018-09-15 Equity shares 2017-09-14 1.5 Final 2017-09-16 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About BRAWN BIOTECH LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by BRAWN BIOTECH LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Brawn Biotech Ltd?

Answer Field

The share price of Brawn Biotech Ltd for NSE is ₹ 0.00 and for BSE is ₹ 21.03.

What is the Market Cap of Brawn Biotech Ltd?

Answer Field

The market cap of Brawn Biotech Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 6.30 Cr. as of now.

What is the 52 Week High and Low of Brawn Biotech Ltd?

Answer Field

The 52 Week High and Low of Brawn Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 27.82 and ₹ 14.63.

How to Buy Brawn Biotech Ltd share?

Answer Field

You can trade in Brawn Biotech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Brawn Biotech Ltd?

Answer Field

The 1 year returns on the stock has been 11.50%.

What is the Current Share Price of Brawn Biotech Ltd?

Answer Field

Brawn Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 21.03 as on Nov 21 2024 03:26 PM.

What is the Market Cap of Brawn Biotech Ltd Share?

Answer Field

The market cap of Brawn Biotech Ltd for NSE ₹ 0.0 & for BSE ₹ 6.30 as on Nov 21 2024 03:26 PM.

What is the P/E Ratio of Brawn Biotech Ltd Share?

Answer Field

As on Nov 21 2024 03:26 PM the price-to-earnings (PE) ratio for Brawn Biotech Ltd share is -3.46.

What is the PB ratio of Brawn Biotech Ltd Share?

Answer Field

As on Nov 21 2024 03:26 PM, the price-to-book (PB) ratio for Brawn Biotech Ltd share is 14.10.

How to Buy Brawn Biotech Ltd Share?

Answer Field

You can trade in Brawn Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Brawn Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Brawn Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Brawn Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader